Muriel Liberto, Mintz

Muriel Liberto, Mintz

Michael Baran, Pfizer Ventures and Chris Barnstable-Brown, WilmerHale

Michael Baran, Pfizer Ventures and Chris Barnstable-Brown, WilmerHale

Steve O'Loughlin, Actinium Pharmaceuticals and Sue Crinnion, JP Morgan Chase

Steve O'Loughlin, Actinium Pharmaceuticals and Sue Crinnion, JP Morgan Chase

Charlotte D'Hulst, Yesse Technologies and Mary Howard

Charlotte D'Hulst, Yesse Technologies and Mary Howard

Michael Baran, Pfizer Ventures

Michael Baran, Pfizer Ventures

Preparing for Due Diligence workshop, 6.27.19

Preparing for Due Diligence workshop, 6.27.19

Craig Keneski, WSGR; Philip Glick, Conner Strong; Phil Bergamo, EisnerAmper

Craig Keneski, WSGR; Philip Glick, Conner Strong; Phil Bergamo, EisnerAmper

Peikwen Cheng, Yiviva and Craig Kenesky, WSGR

Peikwen Cheng, Yiviva and Craig Kenesky, WSGR

Michael Osso,Crohn's & Colitis Foundation, Chad Dyar, Theraputix and Nini Fan

Michael Osso,Crohn's & Colitis Foundation, Chad Dyar, Theraputix and Nini Fan

Mary Howard, ElabNYC | ABCT and Nini Fan and Joseph Morin

Mary Howard, ElabNYC | ABCT and Nini Fan and Joseph Morin

Rotem Lev-Zwickel, Agamon and Matt McCambridge, Eden Health

Rotem Lev-Zwickel, Agamon and Matt McCambridge, Eden Health

Omar Green, Ionica Sciences and Mary Howard, ElabNYC | ABCT

Omar Green, Ionica Sciences and Mary Howard, ElabNYC | ABCT

Krista Fretes, Gentroma

Krista Fretes, Gentroma

Preparing for Due Diligence workshop, 6.27.19

Preparing for Due Diligence workshop, 6.27.19

Fiona Mack, Roche

Fiona Mack, Roche

Fiona Mack, Roche

Fiona Mack, Roche

Steve O'Loughlin, Actinium Pharmaceuticals

Steve O'Loughlin, Actinium Pharmaceuticals

John Pennet, EisnerAmper

John Pennet, EisnerAmper

Sue Crinnion, JP Morgan Chase

Sue Crinnion, JP Morgan Chase

Chris Barnstable-Brown ,WilmerHale

Chris Barnstable-Brown ,WilmerHale

Craig Kenesky, WSGR

Craig Kenesky, WSGR

Phil Bergamo, EisnerAmper

Phil Bergamo, EisnerAmper

Philip Glick, Conner Strong, Phil Bergamo, EisnerAmper and Scott Matarese, Willis Towers Watson

Philip Glick, Conner Strong, Phil Bergamo, EisnerAmper and Scott Matarese, Willis Towers Watson

Mary Howard, ElabNYC | ABCT

Mary Howard, ElabNYC | ABCT

Michael Osso, Crohn's & Colitis Foundation's, Sophia Cacciatore, NYCEDC and Jason Campbell, Global Symmetry

Michael Osso, Crohn's & Colitis Foundation's, Sophia Cacciatore, NYCEDC and Jason Campbell, Global Symmetry

Barry Kappel, Sapience Therapeutics

Barry Kappel, Sapience Therapeutics

Dennis Purcell, Aisling Capital

Dennis Purcell, Aisling Capital

Dennis Purcell, Aisling Capital

Dennis Purcell, Aisling Capital

John Bradley, Torreya Partners

John Bradley, Torreya Partners

John Bradley, Torreya Partners

John Bradley, Torreya Partners

Preparing for Due Diligence workshop, 6.27.19

Preparing for Due Diligence workshop, 6.27.19

Lambert Edelman and Krista Fretes, Gentroma

Lambert Edelman and Krista Fretes, Gentroma

Raymond Alvarez, Ichor Biologics, Amit Bansal,  and Amit Bansal, Digitalis Ventures and Bruce Nemlich, Nemlich BioPharm and Michael Baran, Pfizer Ventures

Raymond Alvarez, Ichor Biologics, Amit Bansal, and Amit Bansal, Digitalis Ventures and Bruce Nemlich, Nemlich BioPharm and Michael Baran, Pfizer Ventures

Mary Howard, ElabNYC | ABCT

Mary Howard, ElabNYC | ABCT

Preparing for Due Diligence workshop, 6.27.19

Preparing for Due Diligence workshop, 6.27.19

Lambert Edelman and Michael Barran, Pfizer Ventures

Lambert Edelman and Michael Barran, Pfizer Ventures

Abby Roberts, Merill Corporation and Chouckri Ben Mamoun, eliv5therapeutics

Abby Roberts, Merill Corporation and Chouckri Ben Mamoun, eliv5therapeutics

Jordan Frey, EisnerAmper

Jordan Frey, EisnerAmper

Preparing for Due Diligence workshop, 6.27.19

Preparing for Due Diligence workshop, 6.27.19

Alan Wink, EisnerAmper, , John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics

Alan Wink, EisnerAmper, , John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics

Alan Wink, EisnerAmper and Mary Howard, ElabNYC | ABCT

Alan Wink, EisnerAmper and Mary Howard, ElabNYC | ABCT

Sonia Gonzalez, StudentBody

Sonia Gonzalez, StudentBody

John Pennett, EisnerAmper

John Pennett, EisnerAmper

Steve O'Loughlin, Actinium Pharmaceuticals

Steve O'Loughlin, Actinium Pharmaceuticals

Fiona Mack, Roche

Fiona Mack, Roche

Muriel Liberto, Mintz

Muriel Liberto, Mintz

Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals

Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals

Thjis Spoor, AzurX BioPharma

Thjis Spoor, AzurX BioPharma

Michael Baran, Pfizer Ventures

Michael Baran, Pfizer Ventures

Sue Crinnion, JP Morgan Chase

Sue Crinnion, JP Morgan Chase

Scott Matarese, Willis Towers Watson

Scott Matarese, Willis Towers Watson

Philip Glick, Conner Strong

Philip Glick, Conner Strong

Scott Matarese, Willis Towers Watson

Scott Matarese, Willis Towers Watson

Jason Campbell, Global Symmetry

Jason Campbell, Global Symmetry

Sophia Cacciatore, NYCEDC

Sophia Cacciatore, NYCEDC

Yaniv Sneor, MABA

Yaniv Sneor, MABA

Alan Roemer, Roivant Sciences

Alan Roemer, Roivant Sciences

Matt McCambridge, Eden Health

Matt McCambridge, Eden Health

Alan Wink, EisnerAmper

Alan Wink, EisnerAmper

Matt McCambridge, Eden Health

Matt McCambridge, Eden Health

Harold Hess and Jordan Frey, EisnerAmper

Harold Hess and Jordan Frey, EisnerAmper

Fiona Mack, Roche

Fiona Mack, Roche

Preparing for Due Diligence workshop, 6.27.19

Preparing for Due Diligence workshop, 6.27.19

Chris Barnstable-Brown, WilmerHale, Thjis Spoor, AzurRX BioPharma, Sundeep Bhan, Prognos, Sue Crinnion, JP Morgan Chase and Michael Baran, Pfizer Ventures

Chris Barnstable-Brown, WilmerHale, Thjis Spoor, AzurRX BioPharma, Sundeep Bhan, Prognos, Sue Crinnion, JP Morgan Chase and Michael Baran, Pfizer Ventures

Mary Howard, ElabNYC | ABCT and Philip Glick, Conner Strong

Mary Howard, ElabNYC | ABCT and Philip Glick, Conner Strong

Jon Zaikowski, CapCell Biologics and Donal Fishbein, Evolve Therapeutics

Jon Zaikowski, CapCell Biologics and Donal Fishbein, Evolve Therapeutics

Mary Howard, ElabNYC Program Director, Chouckri Ben Mamoun, eliv5therapeutics and John Pennett, EisnerAmper

Mary Howard, ElabNYC Program Director, Chouckri Ben Mamoun, eliv5therapeutics and John Pennett, EisnerAmper

Barham Marami and Reza Royaee, Dispomeds

Barham Marami and Reza Royaee, Dispomeds

"Fireside Chat" with Dennis Purcel, Aisling Capital and Alan Roemer, Roivant Sciences

"Fireside Chat" with Dennis Purcel, Aisling Capital and Alan Roemer, Roivant Sciences

Mary Howard, ElabNYC | ABCT and John Bradley, Torreya Partners

Mary Howard, ElabNYC | ABCT and John Bradley, Torreya Partners

Mary Howard, ElabNYC | ABCT and Matt McCambridge, Eden Health

Mary Howard, ElabNYC | ABCT and Matt McCambridge, Eden Health

Chad Dyar, Theraputix, Sonia Gonzalez, StudentBody and Mican Meneses, Menopal

Chad Dyar, Theraputix, Sonia Gonzalez, StudentBody and Mican Meneses, Menopal

Mary Howard, ElabNYC | ABCT

Mary Howard, ElabNYC | ABCT

Muriel Liberto, Mintz; Amit Bansal, Digitalis Ventures; Fiona Mack, Roche; Steve O'Loughlin, Actinium Pharmaceuticals

Muriel Liberto, Mintz; Amit Bansal, Digitalis Ventures; Fiona Mack, Roche; Steve O'Loughlin, Actinium Pharmaceuticals

Amit Bansal, Digitalis Ventures

Amit Bansal, Digitalis Ventures

Muriel Liberto, Mintz, Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals

Muriel Liberto, Mintz, Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals

Mary Howard, ElabNYC Program director

Mary Howard, ElabNYC Program director

Sundeep Bhan, Prognos

Sundeep Bhan, Prognos

Evan Myrianthopoulos, GPB Capital

Evan Myrianthopoulos, GPB Capital

Sue Crinnion, JP Morgan Chase

Sue Crinnion, JP Morgan Chase

Phil Bergamo, EisnerAmper

Phil Bergamo, EisnerAmper

Abby Robberts, Merril Corporation

Abby Robberts, Merril Corporation

Philip Glick, Conner Strong

Philip Glick, Conner Strong

Michael Osso, Crohn's & Colitis Foundation's

Michael Osso, Crohn's & Colitis Foundation's

Meghan Cross Breeden, AmplifyHer Ventures

Meghan Cross Breeden, AmplifyHer Ventures

John Pennett, EisnerAmper

John Pennett, EisnerAmper

Alan Roemer, Roivant Sciences

Alan Roemer, Roivant Sciences

Matt McCambridge, Eden Health

Matt McCambridge, Eden Health

Alan Wink, EisnerAmper, John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics

Alan Wink, EisnerAmper, John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics

Matt McCambridge, Eden Health

Matt McCambridge, Eden Health

Entrepreneurship Lab

BIO AND HEALTH TECH NYC

Corporate Supporters

Community Service Providers

ELabNYC is a Program of

Initiated by

Copyright © 2018 Entrepreneurship Lab NYC